Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092596 · ClinicalTrials.gov registry record · NA
Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings
A NA study of Substance Abuse, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 3,358
- Enrollment target
- 1
- Study location
NCT03092596 is a NA study of Substance Abuse that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 3,358 participants, below the 5,202-participant average among 58 other Substance Abuse trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03092596, a NA study of Substance Abuse, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,358 participants
- Enrollment target
- 1
- Study location
Study Summary
Substance abuse and dependence is highly prevalent among people living with HIV and significantly exacerbates morbidity and mortality and accelerates HIV disease progression. Antiretroviral therapy (ART) has been the single most important treatment for slowing disease progression. ART adherence and HIV primary care are affected by a complex array of factors in the context of lives impacted by socioeconomic, psychological, and health challenges. Drugs and alcohol play a major role in non-adherence, engagement in care, and poor health outcomes among HIV-infected persons. While evidence is unequivocal that substance use treatment improves health outcomes, systems of care for the detection and treatment of substance abuse and dependence remain fragmented. Integrated approaches are key to the delivery of optimal care. Pragmatic or effectiveness trials can provide the best evidence about clinical practice to inform practitioners and policy makes about the most clinically and cost effective treatment to inform dissemination on a wider scale at the organizational and public health levels. The goal of this trial is to develop and test a comprehensive, integrated program to detect and reduce substance abuse and in turn, to improve ART adherence and HIV, substance use and associated health outcomes among HIV-infected patients. This trial will test the effectiveness of the intervention using a stepped wedge trial design to sequentially implement a screening tool and training of patient health navigators at HIV clinics in NYC.
Conditions Studied
Interventions
- BEHAVIORAL Patient-administered screening tool
- BEHAVIORAL Patient health navigator-administered screening tool
- BEHAVIORAL Patient health navigator-assisted linkage to treatment
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,358 participants |
| Start Date | 2017-02-02 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092596
The ClinicalTrials.gov registry entry for NCT03092596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,202-participant average among 58 other Substance Abuse trials with a reported enrollment target (35% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 3 interventions - of which Patient-administered screening tool is the first listed.
NCT03092596 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03092596 about?
NCT03092596 is a clinical study titled "Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings". Substance abuse and dependence is highly prevalent among people living with HIV and significantly exacerbates morbidity and mortality and accelerates HIV disease progression. Antiretroviral therapy (ART) has been the single most important treatment for slowing disease progression. ART adherence and ...
What is the current status of trial NCT03092596?
This trial is currently completed. It is a NA study. The enrollment target is 3,358 participants. The study started on 2017-02-02. Estimated completion is 2020-06-30.
What conditions does trial NCT03092596 study?
This clinical trial studies the following conditions: Substance Abuse.
What interventions are being tested in trial NCT03092596?
The interventions under investigation include: Patient-administered screening tool (BEHAVIORAL), Patient health navigator-administered screening tool (BEHAVIORAL), Patient health navigator-assisted linkage to treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092596?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03092596 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.